AcquiredStartups
Home/North America/Healthtech & bio
Acquisition · Healthtech & bio · United States

IntelyCare acquires hospital staffing app CareRev to cover acute and post-acute care

The deal joins IntelyCare's nursing platform, built around post-acute care, with CareRev's on-demand hospital shift app, which more than 35,000 clinicians use; both brands will stay.

ASAcquired deals deskNorth America8 January 2026 · 3 min read
IntelyCare acquires CareRev
Photo: Shixart1985 / Wikimedia Commons, CC BY 2.0

IntelyCare, a venture-backed healthcare staffing platform, said on January 8, 2026, that it had acquired CareRev, a Sacramento, California, company whose app lets hospitals fill shifts with on-demand nurses and other clinicians.

Financial terms were not disclosed. Matthew Levesque, IntelyCare's chief executive, was named chief executive of both IntelyCare and CareRev.

The two companies will keep operating under their own brands and services, which they said would give customers and clinicians continuity. Hospice News reported that CareRev would not be rebranded after the deal.

What CareRev built

CareRev describes itself as an on-demand workforce platform built for acute care, meaning hospitals and health systems rather than nursing homes or home care. Healthcare professionals use its app to pick shifts and set their own schedules, and hospitals use it to reach a flexible pool of staff. CareRev says this improves clinician well-being and lowers costs for hospitals.

More than 35,000 healthcare professionals use the CareRev app, according to the company. The company is certified by The Joint Commission.

The company was founded in 2015 by Will Patterson, a trauma nurse, according to UNLEASH. By early 2021 it was working with more than 30 hospitals, and it had doubled the number of professionals on its app in the last quarter of 2020.

In the months before the sale, CareRev's own news page listed an expansion of its on-demand platform to allied and ancillary professionals beyond nursing, a new chief nurse executive, Larry Adams, and a new hospital customer in the Dallas-Fort Worth area.

“Our goal is to help healthcare providers operate more efficiently while maintaining consistency and quality across care settings.”Matthew Levesque, CEO, IntelyCare and CareRev
Funding historyTotal raised $55.4m
2021Series ATransformation Capital$50m

Why IntelyCare is buying

IntelyCare's business grew up in post-acute care, connecting nursing facilities and similar providers with nurses. Adding CareRev gives it a product for hospitals, so the combined company can serve both settings.

The companies said their combined offering would include job boards for clinicians, recruiting and sourcing tools, contingent labour and tools for managing a hospital's own internal pool of float staff. The aim, they said, was to let facilities manage permanent staff, internal resource pools and contingent workers through a single technology platform.

Levesque said health systems were under pressure to deliver high-quality care while managing unusually complex workforces, and that the goal was to help providers operate more efficiently while keeping quality consistent across care settings.

The investors behind both companies

CareRev raised a $50 million Series A in April 2021 led by Transformation Capital, a growth fund focused on healthcare IT and services. Industry Ventures, Michael Seibel of Y Combinator and Zach Coelius of Coelius Capital also took part, UNLEASH reported. CB Insights puts CareRev's total funding at about $55.4 million.

Transformation Capital is also an IntelyCare investor. Its managing partner, Jared Kesselheim, said in the announcement that the firm was pleased to keep supporting IntelyCare as it builds a broader workforce platform. Keith Figlioli, managing partner at LRVHealth, an early IntelyCare backer, said the deal would turn IntelyCare's post-acute product into a full-spectrum platform.

IntelyCare is privately held. According to Hospice News, its backers include LRVHealth, Transformation Capital, Endeavour Vision, Revelation Partners and Janus Henderson Investors, and it raised a $115 million Series C in 2022 at a valuation of $1.1 billion. Levesque became IntelyCare's chief executive in July 2024, succeeding David Coppins. The same year, IntelyCare signed a partnership with Trio VMS that gave that company's clients on-demand access to IntelyCare's clinicians, who are employed by IntelyCare as W-2 workers.

What happens to customers

Hospitals that use CareRev and facilities that use IntelyCare will keep working with the same brands and services, the companies said. Over time, the combined company plans to offer both groups a single platform covering permanent staff, internal float pools and contingent workers. Levesque now leads both businesses. The companies did not say whether staff or leadership at CareRev would change.

Sources